The Current Ratio as of December 2024 (TTM) for Kazia Therapeutics Limited (KZIA) is 0.24

According to Kazia Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.24. This represents a change of -72.21% compared to the average of 0.86 of the last 4 quarters.

Kazia Therapeutics Limited (KZIA) Historical Current Ratio (quarterly & annually)

How has KZIA Current Ratio performed in the past?

The mean historical Current Ratio of Kazia Therapeutics Limited over the last ten years is 6.78. The current 0.24 Current Ratio has changed 251.34% with respect to the historical average. Over the past ten years (40 quarters), KZIA's Current Ratio was at its highest in in the September 2015 quarter at 27.14. The Current Ratio was at its lowest in in the September 2022 quarter at 0.

Kazia Therapeutics Limited (KZIA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kazia Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kazia Therapeutics Limited (KZIA) Average Current Ratio

How has KZIA Current Ratio performed in the past?

The current Current Ratio of Kazia Therapeutics Limited (KZIA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kazia Therapeutics Limited (KZIA) Current Ratio vs. Peers

How is KZIA’s Current Ratio compared to its peers?

Kazia Therapeutics Limited’s Current Ratio is less than CytomX Therapeutics, Inc. (1.04), less than Assembly Biosciences, Inc. (2.36), less than Ocular Therapeutix, Inc. (13.01), less than Spero Therapeutics, Inc. (2.68), less than Achilles Therapeutics plc (6.04), less than SELLAS Life Sciences Group, Inc. (2.26), greater than NLS Pharmaceutics AG (0.15), less than Mereo BioPharma Group plc (6.10), less than Aravive, Inc. (0.98), less than Day One Biopharmaceuticals, Inc. (14.62), greater than ZIVO Bioscience, Inc. (0.17), less than RenovoRx, Inc. (5.66), less than Pasithea Therapeutics Corp. (14.81), less than Quoin Pharmaceuticals, Ltd. (3.02), less than ARCA biopharma, Inc. (26.61), less than Bionomics Limited (3.30), greater than OKYO Pharma Limited (0.21), less than Candel Therapeutics, Inc. (1.18), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Cingulate Inc. (7.35), less than Nurix Therapeutics, Inc. (5.28), less than Seer, Inc. (18.36), less than Quantum-Si incorporated (13.42), greater than HCW Biologics Inc. (0.07), less than MediciNova, Inc. (16.66),

Build a custom stock screener for Kazia Therapeutics Limited (KZIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kazia Therapeutics Limited (KZIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kazia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.